Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events

Boers-Doets, C.B.; Gelderblom, H.; Lacouture, M.E.; Epstein, J.B.; Nortier, J.W.R.; Kaptein, A.A. (2013)

Article / Letter to editor

• Epidermal growth factor receptor inhibitors (EGFRI)
• FACT-EGFRI-18
• Mucocutaneous adverse events (mcAE)
• Health-related quality of life (HRQoL)
• Patient-reported outcome questionnaire
• Symptom burden

• All authors: Boers-Doets, C.B.; Gelderblom, H.; Lacouture, M.E.; Epstein, J.B.; Nortier, J.W.R.; Kaptein, A.A.
• Date: 2013-07-31
• Journal: Supportive Care in Cancer
• Volume: 21
• Issue: 7
• Pages: 1919 - 1926
• DOI: doi:10.1007/s00520-013-1752-4